Cargando…
Non-Mass Enhancements on DCE-MRI: Development and Validation of a Radiomics-Based Signature for Breast Cancer Diagnoses
PURPOSE: We aimed to assess the additional value of a radiomics-based signature for distinguishing between benign and malignant non-mass enhancement lesions (NMEs) on dynamic contrast-enhanced breast magnetic resonance imaging (breast DCE-MRI). METHODS: In this retrospective study, 232 patients with...
Autores principales: | Li, Yan, Yang, Zhenlu L., Lv, Wenzhi Z., Qin, Yanjin J., Tang, Caili L., Yan, Xu, Guo, Yihao H., Xia, Liming M., Ai, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493069/ https://www.ncbi.nlm.nih.gov/pubmed/34631572 http://dx.doi.org/10.3389/fonc.2021.738330 |
Ejemplares similares
-
Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence
por: Li, Yan, et al.
Publicado: (2023) -
BI-RADS Reading of Non-Mass Lesions on DCE-MRI and Differential Diagnosis Performed by Radiomics and Deep Learning
por: Zhou, Jiejie, et al.
Publicado: (2021) -
Radiomics Nomogram of DCE-MRI for the Prediction of Axillary Lymph Node Metastasis in Breast Cancer
por: Mao, Ning, et al.
Publicado: (2020) -
Radiomic Evaluations of the Diagnostic Performance of DM, DBT, DCE MRI, DWI, and Their Combination for the Diagnosisof Breast Cancer
por: Niu, Shuxian, et al.
Publicado: (2021) -
3T DCE-MRI Radiomics Improves Predictive Models of Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Montemezzi, Stefania, et al.
Publicado: (2021)